Aarti Drugs Limited has informed the Exchange regarding a press release dated July 31, 2026, titled "Aarti Drugs Limited Announces Leadership Transition to Strengthen Governance and Ensure Long-Term Strategic Growth".
Aarti Drugs Limited Press Release Jul 31 2026
Filed with NSE · · 4 pages · English
Summary by 6ix AI
Aarti Drugs Limited has announced a leadership transition to enhance governance and support long-term growth strategies. Shri Prakash M. Patil will retire from his roles as Chairman, Managing Director, and CEO, but will remain involved for guidance during the transition. The changes are part of a structured succession plan aimed at maintaining continuity while fostering renewal within the company's leadership.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
In the deck
Earlier from Aarti Drugs
- Press Release May 16 2026
- Press Release Apr 06 2026
- Press Release Feb 03 2026
- Press Release Nov 07 2025
- Press Release Aug 21 2025
Later from Aarti Drugs
- Aarti Drugs Limited Press Release Aug 01 2026
- Aarti Drugs Limited has informed the Exchange regarding a press release dated November 03, 2026, titled "Q2&H1FY27 Business and Financial Performance".
Follow Aarti Drugs into a list and get an email when it puts out news.
Follow Aarti Drugs